CoChat

Astrocytes in Tauopathies

Reid, Matthew J., Beltran-Lobo, Paula, Johnson, Louisa, Perez-Nievas, Beatriz Gomez, Noble, Wendy · 2020 · Frontiers in Neurology
Cited by 84

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Tauopathies are a group of neurodegenerative diseases characterized by the progressive accumulation across the brain of hyperphosphorylated aggregates of the microtubule-associated protein tau that vary in isoform composition, structural conformation and localization. Tau aggregates are most commonly deposited within neurons but can show differential association with astrocytes, depending on the disease. Astrocytes, the most abundant neural cells in the brain, play a major role in synapse and neuronal function, and are a key component of the glymphatic system and blood brain barrier. However, their contribution to tauopathy progression is not fully understood. Here we present a brief overview of the association of tau with astrocytes in tauopathies. We discuss findings that support a role for astrocytes in the uptake and spread of pathological tau, and we describe how alterations to astrocyte phenotype in tauopathies may cause functional alterations that impedes their ability to support neurons and/or cause neurotoxicity. The research reviewed here further highlights the importance of considering non-neuronal cells in neurodegeneration and suggests that astrocyte-directed targets that may have utility for therapeutic intervention in tauopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2020.572850

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Astrocytic mechanisms that may contribute to spread of tau pathology. (1) Tau monomers and aggregates are released from neurons via various mechanisms, including from the pre-synapse, (2) Astrocytes have specific HSPGs and receptors such as LDR1 that may mediate the uptake of tau aggregates, (3) These aggregates may be internalized and processed by various mechanisms, include lysosomal degradation, (4) Disruption of AQP4 in perivascular astrocytic end-feet may contribute to the disrupted tau clearance and the accumulation of tau aggregates in the CNS. HSPG, heparin sulfate proteoglycan; LDR1, low density lipoprotein receptor-related protein 1; AQP4, aquaporin-4.
Figure 1 Astrocytic mechanisms that may contribute to spread of tau pathology. (1) Tau monomers and aggregates are released from neurons via various mechanisms, including from the pre-synapse, (2) Astrocytes have specific HSPGs and receptors such as LDR1 that may mediate the uptake of tau aggregates, (3) These aggregates may be internalized and processed by various mechanisms, include lysosomal degradation, (4) Disruption of AQP4 in perivascular astrocytic end-feet may contribute to the disrupted tau clearance and the accumulation of tau aggregates in the CNS. HSPG, heparin sulfate proteoglycan; LDR1, low density lipoprotein receptor-related protein 1; AQP4, aquaporin-4.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 66

  1. Binder, 1985, The distribution of tau in the mammalian central nervous system, J Cell Biol., 101, 1371, 10.1083/jcb.101.4.1371 · DOI · Paper page
  2. Darmanis, 2015, A survey of human brain transcriptome diversity at the single cell level, Proc Natl Acad Sci USA., 112, 7285, 10.1073/pnas.1507125112 · DOI · Paper page
  3. Falcon, 2018, Structures of filaments from Pick's disease reveal a novel tau protein fold, Nature, 561, 137, 10.1038/s41586-018-0454-y · DOI · Paper page
  4. Falcon, 2019, Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules, Nature., 568, 420, 10.1038/s41586-019-1026-5 · DOI · Paper page
  5. Zhang, 2020, Novel tau filament fold in corticobasal degeneration, Nature., 580, 283, 10.1038/s41586-020-2043-0 · DOI · Paper page
  6. Forrest, 2019, Cellular and regional vulnerability in frontotemporal tauopathies, Acta Neuropathol., 138, 705, 10.1007/s00401-019-02035-7 · DOI
  7. Forrest, 2018, Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies, Brain, 141, 521, 10.1093/brain/awx328 · DOI · Paper page
  8. Dickson, 2001, Neuropathology of Pick's disease, Neurology, 56, S16, 10.1212/WNL.56.suppl_4.S16 · DOI
  9. Josephs, 2011, Neuropathological background of phenotypical variability in frontotemporal dementia, Acta Neuropathol., 122, 137, 10.1007/s00401-011-0839-6 · DOI · Paper page
  10. Ferrer, 2014, Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression, J Neuropathol Exp Neurol, 73, 81, 10.1097/NEN.0000000000000030 · DOI · Paper page
  11. Kovacs, 2010, Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases, Clin Neuropathol., 29, 271, 10.5414/NPP29271 · DOI · Paper page
  12. Ling, 2016, Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology, Brain, 139, 3237, 10.1093/brain/aww256 · DOI
  13. Botez, 1999, Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease, Acta Neuropathol., 98, 251, 10.1007/s004010051077 · DOI
  14. Rodriguez, 2015, Argyrophilic grain disease: an underestimated tauopathy, Dement Neuropsychol., 9, 2, 10.1590/S1980-57642015DN91000002 · DOI · Paper page
  15. Saito, 2004, Staging of argyrophilic grains: an age-associated tauopathy, J Neuropathol Exp Neurol., 63, 911, 10.1093/jnen/63.9.911 · DOI · Paper page
  16. Ahmed, 2013, Globular glial tauopathies (GGT): consensus recommendations, Acta Neuropathol., 126, 537, 10.1007/s00401-013-1171-0 · DOI · Paper page
  17. Kovacs, 2018, Understanding the Relevance of Aging-Related Tau Astrogliopathy (ARTAG), Neuroglia, 1, 339, 10.3390/neuroglia1020023 · DOI
  18. Kovacs, 2017, Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases, J Neuropathol Exp Neurol., 76, 270, 10.1093/jnen/nlx007 · DOI · Paper page
  19. Lane, 2018, Alzheimer's disease, Eur J Neurol., 25, 59, 10.1111/ene.13439 · DOI · Paper page
  20. Jellinger, 2015, PART, a distinct tauopathy, different from classical sporadic Alzheimer disease, Acta Neuropathol., 129, 757, 10.1007/s00401-015-1407-2 · DOI · Paper page
  21. Stein, 2014, Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel, Alzheimers Res Ther., 6, 4, 10.1186/alzrt234 · DOI · Paper page
  22. Parpura, 1994, Glutamate-mediated astrocyte-neuron signalling, Nature., 369, 744, 10.1038/369744a0 · DOI · Paper page
  23. Oberheim, 2006, Astrocytic complexity distinguishes the human brain, Trends Neurosci., 29, 547, 10.1016/j.tins.2006.08.004 · DOI · Paper page
  24. Volterra, 2005, Astrocytes, from brain glue to communication elements: the revolution continues, Nat Rev Neurosci., 6, 626, 10.1038/nrn1722 · DOI · Paper page
  25. Choi, 2014, Human astrocytes: secretome profiles of cytokines and chemokines, PLoS ONE., 9, e92325, 10.1371/journal.pone.0092325 · DOI · Paper page
  26. Mederos, 2018, Astrocyte–neuron networks: a multilane highway of signaling for homeostatic brain function, Front Synaptic Neurosci., 10, 45, 10.3389/fnsyn.2018.00045 · DOI
  27. Lushnikova, 2009, Synaptic potentiation induces increased glial coverage of excitatory synapses in CA1 Hippocampus, 762, 753, 10.1002/hipo.20551 · DOI · Paper page
  28. Kersaitis, 2004, Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies, Acta Neuropathol., 108, 515, 10.1007/s00401-004-0917-0 · DOI
  29. Acosta, 2017, Astrocyte dysfunction in Alzheimer disease, J Neurosci Res., 95, 2430, 10.1002/jnr.24075 · DOI · Paper page
  30. Osborn, 2016, Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease, Prog Neurobiol., 144, 121, 10.1016/j.pneurobio.2016.01.001 · DOI · Paper page
  31. Wruck, 2020, Meta-analysis of human prefrontal cortex reveals activation of GFAP and decline of synaptic transmission in the aging brain, Acta Neuropathol Commun., 8, 1, 10.1186/s40478-020-00907-8 · DOI
  32. Habib, 2020, Disease-associated astrocytes in Alzheimer's disease and aging, Nat Neurosci, 23, 701, 10.1038/s41593-020-0624-8 · DOI · Paper page
  33. Piacentini, 2017, Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons, Glia, 65, 1302, 10.1002/glia.23163 · DOI
  34. Shigetomi, 2019, Aberrant calcium signals in reactive astrocytes: a key process in neurological disorders, Int J Mol Sci., 20, 996, 10.3390/ijms20040996 · DOI · Paper page
  35. Phillips, 2013, Astrocytes and neuroinflammation in Alzheimer's disease, Biochem Soc Trans., 42, 1321, 10.1042/BST20140155 · DOI
  36. Bright, 2019, Neuroinflammation in frontotemporal dementia, Nat Rev Neurol., 15, 540, 10.1038/s41582-019-0231-z · DOI · Paper page
  37. Sadick, 2019, Don't forget astrocytes when targeting Alzheimer's disease, Br J Pharmacol, 176, 3585, 10.1111/bph.14568 · DOI
  38. Boisvert, 2018, The aging astrocyte transcriptome from multiple regions of the mouse brain, Cell Rep., 22, 269, 10.1016/j.celrep.2017.12.039 · DOI · Paper page
  39. Ling, 2020, Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates, Acta Neuropathol., 139, 717, 10.1007/s00401-019-02119-4 · DOI
  40. Besser, 2017, Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy, Neurology., 89, 1707, 10.1212/WNL.0000000000004521 · DOI · Paper page
  41. Jellinger, 2018, Different patterns of hippocampal tau pathology in Alzheimer's disease and PART, Acta Neuropathol., 136, 811, 10.1007/s00401-018-1894-z · DOI
  42. McKee, 2013, The spectrum of disease in chronic traumatic encephalopathy, Brain, 136, 43, 10.1093/brain/aws307 · DOI · Paper page
  43. Clavaguera, 2013, Brain homogenates from human tauopathies induce tau inclusions in mouse brain, Proc Natl Acad Sci USA., 110, 9535, 10.1073/pnas.1301175110 · DOI · Paper page
  44. He, 2020, Transmission of tauopathy strains is independent of their isoform composition, Nat Commun, 11, 7, 10.1038/s41467-019-13787-x · DOI · Paper page
  45. Liu, 2012, Trans-synaptic spread of tau pathology in vivo, PLoS ONE, 7, 1, 10.1371/journal.pone.0031302 · DOI · Paper page
  46. Turnbull, 2001, Heparan sulfate: decoding a dynamic multifunctional cell regulator, Trends Cell Biol., 11, 75, 10.1016/S0962-8924(00)01897-3 · DOI · Paper page
  47. Sarrazin, 2011, Heparan Sulfate Proteoglycans, Cold Spring Harb Perspect Biol., 3, a004952, 10.1101/cshperspect.a004952 · DOI · Paper page
  48. Schonberger, 2003, Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis, Biochem Biophys Res Commun., 312, 473, 10.1016/j.bbrc.2003.10.150 · DOI
  49. Horonchik, 2005, Heparan sulfate is a cellular receptor for purified infectious prions, J Biol Chem., 280, 17062, 10.1074/jbc.M500122200 · DOI · Paper page
  50. Ihse, 2017, Cellular internalization of alpha- synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type, Sci Rep, 7, 9008, 10.1038/s41598-017-08720-5 · DOI · Paper page
  51. Puangmalai, 2020, Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer ' s disease, progressive supranuclear palsy and dementia with Lewy bodies, Cell Death Dis., 11, 314, 10.1038/s41419-020-2503-3 · DOI
  52. Stopschinski, 2018, Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus -synuclein and -amyloid aggregates, J Biol Chem., 293, 10826, 10.1074/jbc.RA117.000378 · DOI · Paper page
  53. Tselnicker, 2014, The role of neuronal versus astrocyte-derived heparan sulfate proteoglycans in brain development and injury, Biochem Soc Trans., 42, 1263, 10.1042/BST20140166 · DOI · Paper page
  54. Benarroch, 2007, Aquaporin-4, homeostasis, and neurologic disease, Neurology, 69, 2266, 10.1212/01.wnl.0000286385.59836.e2 · DOI
  55. Ferrer, 2018, Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes, Brain Pathol, 28, 965, 10.1111/bpa.12593 · DOI · Paper page
  56. Han, 1998, Regulation of aquaporin-4 water channels by phorbol ester-dependent protein phosphorylation, J Biol Chem., 273, 6001, 10.1074/jbc.273.11.6001 · DOI · Paper page
  57. Kitchen, 2015, Identification and molecular mechanisms of the rapid tonicity-induced relocalization of the aquaporin 4 channel, J Biol Chem., 290, 16873, 10.1074/jbc.M115.646034 · DOI · Paper page
  58. Sidoryk-Wegrzynowicz, 2017, Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions, Acta Neuropathol Commun., 5, 89, 10.1186/s40478-017-0478-9 · DOI · Paper page
  59. Hasel, 2017, Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism, Nat Commun, 8, 15132, 10.1038/ncomms15132 · DOI · Paper page
  60. Hallmann, 2017, Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein, Sci Rep., 7, 1, 10.1038/srep42991 · DOI
  61. Veerhuis, 2011, Complement in the brain, Mol Immunol., 48, 1592, 10.1016/j.molimm.2011.04.003 · DOI · Paper page
  62. Lian, 2016, Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of alzheimer's disease, J Neurosci., 36, 577, 10.1523/JNEUROSCI.2117-15.2016 · DOI · Paper page
  63. Wu, 2019, Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy article, Cell Rep., 28, 2111, 10.1016/j.celrep.2019.07.060 · DOI · Paper page
  64. Henstridge, 2019, Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration, Front Cell Neurosci., 13, 63, 10.3389/fncel.2019.00063 · DOI · Paper page
  65. Noble, 2019, Sleep well to slow Alzheimer's progression?, Science, 363, 813, 10.1126/science.aaw5583 · DOI
  66. Bellesi, 2017, Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex, J Neurosci, 37, 5263, 10.1523/JNEUROSCI.3981-16.2017 · DOI · Paper page

Cited by

See all 84

Metadata

Authors
Reid, M. J., Beltran-Lobo, P., Johnson, L., Perez-Nievas, B. G., & Noble, W.
Venue
Frontiers in Neurology
Published
2020-09-24
Volume
11
ISSN
1664-2295
Cited by
84
References
49

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Astrocytes in Tauopathies. https://app.cochat.ai/papers/10.3389/fneur.2020.572850
The paper
Reid, M. J., Beltran-Lobo, P., Johnson, L., Perez-Nievas, B. G., & Noble, W. (2020). Astrocytes in Tauopathies. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.572850

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.